The Indian Journal of Pediatrics

, Volume 47, Issue 6, pp 481–482 | Cite as

Levamisole therapy in Indian childhood cirrhosis

  • B. Sharda
  • B. Bhandari
Original Article


Nine histopathologically proved cases of ICC were treated with the immunopotentiating agent levamisole. Equal number of ICC patients were on steroid treatment and served as controls. Fatal outcome was invariable in both groups. The duration of treatment i.e. from beginning of treatment to death did not differ in the two groups. It is concluded that levamisole in the doses given has no therapeutic value in ICC.


Fatal Outcome Levamisole Obstructive Jaundice Intrahepatic Cholestasis Spleen Size 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Chandra RK: Immunologic picture in I.C.C. Lancet i: 537, 1970CrossRefGoogle Scholar
  2. 2.
    Chandra RK, Chawla V, Verma IC, Ghai OP: HAA and depressed cellular immunity in ICC. Am J Dis Child 123:408, 1972PubMedGoogle Scholar
  3. 3.
    Symoens J, Rosenthal M: Levamisole in the modulation of immune response. J Reticuloendothel Soc21:175, 1977PubMedGoogle Scholar
  4. 4.
    Nayak NC, Ramalingaswami V: Indian childhood cirrhosis. Clin Gastroenterology 4:333, 1975Google Scholar
  5. 5.
    Tanphaichitr P, Tanphaichir D, Sureeratanan J, Chatasingh S: Treatment of nephrotic syndrome with levamisole. J Pediatr 96:490, 1980.PubMedCrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 1980

Authors and Affiliations

  • B. Sharda
    • 1
  • B. Bhandari
    • 1
  1. 1.Department of PediatricsMedical CollegeUdaipurIndia

Personalised recommendations